Clinicopathological Factors Associated with Oncotype DX Risk Group in Patients with ER+/HER2- Breast Cancer

SIMPLE SUMMARY: Oncotype DX (ODX) is a gene assay that can predict the recurrence risk in patients with early breast cancer. We aimed to evaluate clinicopathological factors that can predict the ODX risk group as an alternative to this expensive assay. A total of 547 patients with estrogen receptor-...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Ran, Lee, Dong-Eun, Lee, Eun-Gyeong, Lee, Seeyoun, Kang, Han-Sung, Han, Jai Hong, Lee, Keun Seok, Sim, Sung Hoon, Chae, Heejung, Kwon, Youngmee, Woo, Jaeyeon, Jung, So-Youn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527468/
https://www.ncbi.nlm.nih.gov/pubmed/37760420
http://dx.doi.org/10.3390/cancers15184451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527468/
https://www.ncbi.nlm.nih.gov/pubmed/37760420
http://dx.doi.org/10.3390/cancers15184451

Ejemplares similares